Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil

Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil

The emergence of immune checkpoint inhibitors (ICIs) has significantly prolonged the survival time of cancer patients. However, it may also lead to various immune-related adverse events (irAEs), including Guillain–Barré syndrome (GBS), a rare type of irAE. Most GBS patients can recover spontaneously...

Full description

Bibliographic Details
Main Authors: Mengge Ding, Chao Deng, Xianling Liu, Shun Jiang, Yuan Gao, Dan Fan, Yiguang Zhou, Jiangbo He, Chaoyuan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Guillain–Barré syndrome
immune checkpoint inhibitors
immune-related adverse events
KN046
mycophenolate mofetil
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1132692/full

Similar Items

Similar Items